Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 5/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.34 |
| ▸ | SELE | P16581 | 1/20 | 0.34 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.34 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20893420 | 0.82 | MEN1 (0.53) | GABRA1GABRB2MEN1KMT2ANPC1 | |
| SCHEMBL2360344 | 0.82 | GABRA1 (0.46) | GABRA1GABRB2L3MBTL1TP53MEN1 | |
| SCHEMBL3654540 | 0.80 | MEN1 (0.39) | GABRA1GABRB2L3MBTL1TP53MEN1 | |
| SCHEMBL2360291 | 0.76 | GABRA1 (0.39) | GABRA1GABRB2L3MBTL1MEN1KMT2A | |
| SCHEMBL28532339 | 0.76 | GABRA1 (0.39) | GABRA1GABRB2L3MBTL1MEN1KMT2A | |
| SCHEMBL3798167 | 0.76 | GABRA1 (0.39) | GABRA1GABRB2L3MBTL1MEN1KMT2A | |
| SCHEMBL9412069 | 0.76 | ALDH1A1 (0.51) | GABRA1GABRB2L3MBTL1MEN1KMT2A | |
| SCHEMBL3655835 | 0.75 | GABRA1 (0.39) | GABRA1GABRB2L3MBTL1TP53MEN1 | |
| SCHEMBL6217179 | 0.74 | KMT2A (0.41) | MEN1KMT2ANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL29929393 | 0.73 | ALDH1A1 (0.47) | HPGDSMN1; SMN2ALDH1A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1858841-B1 | COMPOSITION FOR STERILIZATION COMPRISING OMEGA-ALKOXYPEROXYCARBOXYLIC ACID | FUJIFILM CORP (JP) | 2014-11-26 | — | — | EP | disclosed |
| US-7666354-B2 | Composition for sterilization comprising ω-alkoxyperoxycarboxylic acid | FUJIFILM CORPORATION (JP) | 2010-02-23 | — | — | US | disclosed |
| EP-1858841-A4 | COMPOSITION FOR STERILIZATION COMPRISING w-ALKOXYPEROXYCARBOXYLIC ACID | FUJIFILM CORP (JP) | 2009-03-18 | — | — | EP | disclosed |
| US-20080009549-A1 | Composition for Sterilization Comprising W-Alkoxyperoxycarboxylic Acid | FUJIFILM CORPORATION (JP) | 2008-01-10 | — | — | US | disclosed |
| EP-1858841-A2 | COMPOSITION FOR STERILIZATION COMPRISING w-ALKOXYPEROXYCARBOXYLIC ACID | FUJIFILM Corporation (JP) | 2007-11-28 | — | — | EP | disclosed |
| US-20070179193-A1 | Method for preparing aqueous composition for sterilization | FUJIFILM CORPORATION (JP) | 2007-08-02 | — | — | US | disclosed |
| EP-1803350-A2 | Method for preparing aqueous composition for sterilization | Fujifilm Corporation (JP) | 2007-07-04 | — | — | EP | disclosed |
| WO-2006068306-A2 | COMPOSITION FOR STERILIZATION COMPRISING ω-ALKOXYPEROXYCARBOXYLIC ACID | FUJIFILM CORPORATION (JP) | 2006-06-29 | — | — | WO | disclosed |
| US-5900256-A | AQUEOUS, CORROSION RESISTANCE | COTTRELL, LTD. (US) | 1999-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080009549-A1 | Composition for Sterilization Comprising W-Alkoxyperoxycarboxylic Acid | OGDH, OXGR1, AKR1C3 | GABRA1 848/4885GABRB2 1153/4885L3MBTL1 2893/4885 |
| US-20070179193-A1 | Method for preparing aqueous composition for sterilization | CYP19A1, OGDH, SDHB | GABRA1 1368/4885GABRB2 1504/4885L3MBTL1 4848/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.